Timing Pharmaceutical Co

Timing Pharmaceutical Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Timing Pharmaceutical Co (6659.TWO) as of Oct 14, 2026 is 66.40 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 95.34 M TWD — a change of -30.36% (lower).

EBITDA

66.40 MTWD

YoY

-30.36%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Timing Pharmaceutical Co is 2024 66.40 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Timing Pharmaceutical Co was 2023 95.34 M TWD. It decreases by -30.36% lower compared to the previous year.

The Timing Pharmaceutical Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2022
81.22 M TWD
Jan 1, 2023
95.34 M TWD
Jan 1, 2024
66.40 M TWD
The Timing Pharmaceutical Co EBITDA history
YEAREBITDAYoY
66.40 MTWD-30.36%
95.34 MTWD+17.39%
81.22 MTWD—
Access this data via the Eulerpool API
Get Free API Key

Timing Pharmaceutical Co Stock analysis

What does Timing Pharmaceutical Co do? Timing Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Timing Pharmaceutical Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Timing Pharmaceutical Co is 66.40 M TWD in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Timing Pharmaceutical Co changed from 95.34 M TWD to 66.40 M TWD, representing a -30.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Timing Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Timing Pharmaceutical Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Timing Pharmaceutical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Timing Pharmaceutical Co